The Chemours Company
CC
$16.97
-$1.02-5.67%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 5.81B | 5.84B | 5.85B | 5.79B | 5.78B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.81B | 5.84B | 5.85B | 5.79B | 5.78B |
| Cost of Revenue | 4.90B | 4.82B | 4.79B | 4.69B | 4.64B |
| Gross Profit | 908.00M | 1.01B | 1.07B | 1.10B | 1.14B |
| SG&A Expenses | 509.00M | 575.00M | 605.00M | 579.00M | 594.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.52B | 5.51B | 5.50B | 5.38B | 5.34B |
| Operating Income | 291.00M | 332.00M | 350.00M | 408.00M | 440.00M |
| Income Before Tax | -277.00M | -210.00M | -293.00M | 37.00M | 107.00M |
| Income Tax Expenses | 109.00M | 126.00M | 135.00M | 25.00M | 37.00M |
| Earnings from Continuing Operations | -386.00 | -336.00 | -428.00 | 12.00 | 70.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 0.00 | -1.00M | -1.00M | -- | -- |
| Net Income | -386.00M | -337.00M | -429.00M | 12.00M | 70.00M |
| EBIT | 291.00M | 332.00M | 350.00M | 408.00M | 440.00M |
| EBITDA | 631.00M | 642.00M | 654.00M | 706.00M | 732.00M |
| EPS Basic | -2.57 | -2.24 | -2.86 | 0.08 | 0.47 |
| Normalized Basic EPS | 0.26 | 0.43 | 0.51 | 0.76 | 0.92 |
| EPS Diluted | -2.58 | -2.25 | -2.87 | 0.06 | 0.45 |
| Normalized Diluted EPS | 0.26 | 0.43 | 0.51 | 0.76 | 0.92 |
| Average Basic Shares Outstanding | 600.94M | 600.31M | 599.68M | 598.86M | 597.97M |
| Average Diluted Shares Outstanding | 601.41M | 600.77M | 599.68M | 599.57M | 599.70M |
| Dividend Per Share | 0.51 | 0.68 | 0.84 | 1.00 | 1.00 |
| Payout Ratio | -20.21% | -29.38% | -28.90% | 1,233.33% | 211.43% |